PSA launches bold five-year plan for pharmacy

A new vision for the role of pharmacists launched PSA18 in Sydney today, with the unveiling of PSA’s Pharmacists in 2023: A Discussion Paper,...

Two important new updates to diabetes management

Changes to the National Diabetes Services Scheme (NDSS) now allow more people to access the Continuous Glucose Monitoring (CGM) products available under the scheme...

PBS listings for cancer, Parkinson’s and motor neurone disease

Since 1 April, medicines crucial to those suffering from cancer, Parkinson’s and motor neurone disease have become available on the Pharmaceutical Benefits Scheme (PBS). The...

Don’t judge the obese

Most people with clinically severe obesity live and die without the underlying disease having ever been treated, leading global expert in obesity, Professor John...

Collaborate to identify and resolve drug-related problems

An Australian study indicates pharmacists should play a larger role in identifying and resolving drug-related problems (DRPs) as part of a collaborative general practice...

We must embrace change and lead new models of care

Since becoming National President, I have received significant levels of feedback in support of PSA’s development of pharmacists working in general practice. I have also...